Clinical trial
Real World Study of the Effectiveness and Safety of Conbercept Ophthalmic Injection in the Treatment of Retinopathy of Prematurity - Multicenter, Retrospective and Observational Study Based on Real World Data
NCT04985448 is registered in ClinicalTrials.gov with Chengdu Kanghong Biotech Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real World Study of the Effectiveness and Safety of Conbercept Ophthalmic Injection in the Treatment of Retinopathy of Prematurity - Multicenter, Retrospective and Observational Study Based on Real World Data
- Lead sponsor
- Chengdu Kanghong Biotech Co., Ltd.
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 30, 2022
- Completion date
- October 31, 2022
- Enrollment
- 1,000 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.